5.1
Further research is required to determine the place of capecitabine and tegafur with uracil in the treatment of metastatic colorectal cancer. In particular, RCTs are needed to assess the use of these oral treatments compared with infusional 5-FU/FA regimens. Such studies should include evaluations of quality of life, acceptability and cost effectiveness.